HORSERACING TESTING LABS COMMITTEE APPROVES ACCREDITATION OF NEW YORK DRUG TESTING LAB
PENNSYLVANIA 10TH STATE TO ADOPT NATIONAL UNIFORM MEDICATION PROGRAM
Striving to develop and promote uniform rules, policies and testing standards at the national level; coordinate research and educational programs that seek to ensure the integrity of racing and the health and welfare of racehorses and participants; and protect the interests of the racing public.
RMTC FAQ Series
Q: What is the recommended withdraw time for corticosteroid use IM, SQ, or in the sacroiliac space?
A: When using corticosteroids IM, SQ or in the sacroilliac space – the veterinarian and trainer are encouraged to perform a risk assessment regarding the time recommended for withdrawal based upon the dose and formulation of corticosteroid used. The appropriate time will be largely dependent upon dose, location, and corticosteroid of choice. There are published research articles regarding methylprednisolone acetate and triamcinolone acetonide that should assist the veterinarian in determining what may be an appropriate withdrawal time. Furthermore, there is an RMTC recommended time for SQ use of isoflupredone when injected into the high suspensory. #RMTC
The Arabian Jockey Club is a fervent supporter of the efforts of the Racing Medication & Testing Consortium. For more information, visit www.RMTCnet.com